TREA

90160122 - SINTBILO

Follow

Information

  • Trademark
  • 90160122
  • Serial Number
    90160122
  • Registration Number
    6572234
  • Filing Date
    September 04, 2020
    4 years ago
  • Registration Date
    November 30, 2021
    3 years ago
  • Transaction Date
    November 30, 2021
    3 years ago
  • Status Date
    November 30, 2021
    3 years ago
  • Published for Opposition Date
    September 14, 2021
    3 years ago
  • Location Date
    November 30, 2021
    3 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    WHITE, TRAVIS WILLIAM
  • Attorney Name
    Anessa Owen Kramer
    Law Office Assigned Location Code
    N80
  • Owners
Information
Mark Drawing Code
3000
Mark Identification
SINTBILO
Case File Statements
  • DM0000: The mark consists of a circle from which thirteen rounded shapes protrude, two such shapes appearing to drift off to the left, with one small circle appearing above and to the left of the larger circle, with the word "SINTBILO" appearing to the right.
  • GS0051: Pharmaceutical preparations, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; vaccines; drugs in the nature of pharmaceutical preparations for medical purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; biological preparations for medical purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; medicines for human purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; pharmaceuticals contained in syringe for treating cancer or tumor; chemical preparations for medical purposes, namely, preparations used for treating tumor, ophthalmology diseases, cardiovascular diseases immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, and antivirals; dietetic foods adapted for medical use; biological preparations for veterinary purposes for the treatment of tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer and antivirals; diagnostic preparations for medical purposes
Case File Event Statements
  • 11/30/2021 - 3 years ago
    24 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 9/14/2021 - 3 years ago
    23 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 9/14/2021 - 3 years ago
    22 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 9/14/2021 - 3 years ago
    21 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 9/14/2021 - 3 years ago
    20 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 8/26/2021 - 3 years ago
    19 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 8/26/2021 - 3 years ago
    18 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 8/26/2021 - 3 years ago
    17 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 8/6/2021 - 3 years ago
    16 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 8/6/2021 - 3 years ago
    15 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 8/6/2021 - 3 years ago
    14 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 8/6/2021 - 3 years ago
    13 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 8/6/2021 - 3 years ago
    12 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 7/23/2021 - 3 years ago
    11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/23/2021 - 3 years ago
    10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/23/2021 - 3 years ago
    9 - ASSIGNED TO LIE Type: ALIE
  • 7/14/2021 - 3 years ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 1/20/2021 - 3 years ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 1/20/2021 - 3 years ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 1/20/2021 - 3 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 1/12/2021 - 4 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 10/10/2020 - 4 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 10/9/2020 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 9/8/2020 - 4 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP